Healthcare & Life Sciences
Asceneuron
Switzerlandwww.asceneuron.com/
Asceneuron is a Healthcare & Life Sciences startup based in Switzerland, most recent round Series C+, 2 tracked investors.
Activeseries-c-plus
series-c-plus
Stage
2015
Founded
2
Investors
About Asceneuron
Asceneuron is a startup founded in 2015 based in Switzerland. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Asceneuron is a clinical-stage biotechnology company developing novel orally available therapeutics for neurodegenerative diseases. Their lead compound, ASN90, is an O-GlcNAcase inhibitor currently in clinical development for Multiple System Atrophy.
Explore Asceneuron's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.